Abstract
Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) with R/R MCL: Subgroup Analyses in Pts with High-Risk Disease Features from the MCL Cohort of the TRANSCEND NHL 001
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have